Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection
- PMID: 11454922
Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection
Abstract
Previously, we showed that long-circulating polyethylene glycol (PEG)-liposomes are cleared rapidly from the circulation when injected repeatedly in the same animal. In this article, we describe the effects of PEG-coating, the circulation time, the lipid dose, and the presence of encapsulated doxorubicin on the pharmacokinetics upon repeated injection in rats. Furthermore, the role of liver and splenic macrophages was investigated. Liposomes without PEG-coating also showed the so-called "enhanced clearance effect": blood levels at 4 h post injection decreased from 62.8 +/- 13.7% of injected dose (%ID) after the first injection to 0.54 +/- 0.21%ID after the second injection. This decrease was independent of the circulation time of the first dose. Decreasing the first lipid dose of PEG-liposomes to 0.05 micromol/kg still led to enhanced clearance of a second dose of 5 micromol/kg. No changes in pharmacokinetics were observed when the second dose was 50 micromol/kg. When hepatosplenic macrophages were depleted, no enhanced clearance of repeated liposome injections was observed. A dose of doxorubicin containing PEG-liposomes (Doxil), injected 1 week after injection of empty PEG-liposomes, was cleared rapidly from the circulation in rats. Our results indicate that hepatosplenic macrophages play an essential role in the enhanced clearance effect and that the change in pharmacokinetic behavior upon repeated injection is a general characteristic of liposomes, unrelated to the presence of PEG. Therefore, these findings may have a considerable impact on the clinical application of liposomal formulations that are administered repeatedly.
Similar articles
-
Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.J Control Release. 2006 Oct 27;115(3):251-8. doi: 10.1016/j.jconrel.2006.08.017. Epub 2006 Sep 3. J Control Release. 2006. PMID: 17045355
-
Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose.J Pharmacol Exp Ther. 2000 Jun;293(3):996-1001. J Pharmacol Exp Ther. 2000. PMID: 10869403
-
Accelerated blood clearance of PEGylated liposomes containing doxorubicin upon repeated administration to dogs.Int J Pharm. 2012 Oct 15;436(1-2):636-43. doi: 10.1016/j.ijpharm.2012.07.049. Epub 2012 Jul 28. Int J Pharm. 2012. PMID: 22850293
-
In vivo applications of PEG liposomes: unexpected observations.Crit Rev Ther Drug Carrier Syst. 2001;18(6):551-66. Crit Rev Ther Drug Carrier Syst. 2001. PMID: 11789675 Review.
-
Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes.Int J Pharm. 2008 Apr 16;354(1-2):56-62. doi: 10.1016/j.ijpharm.2007.11.005. Epub 2007 Nov 9. Int J Pharm. 2008. PMID: 18083313 Review.
Cited by
-
Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles.Int J Nanomedicine. 2012;7:2891-900. doi: 10.2147/IJN.S30943. Epub 2012 Jun 12. Int J Nanomedicine. 2012. PMID: 22745552 Free PMC article.
-
Accelerated drug release and clearance of PEGylated epirubicin liposomes following repeated injections: a new challenge for sequential low-dose chemotherapy.Int J Nanomedicine. 2013;8:1257-68. doi: 10.2147/IJN.S41701. Epub 2013 Mar 28. Int J Nanomedicine. 2013. PMID: 23576868 Free PMC article.
-
A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified Therapeutics.Pharm Res. 2018 Oct 2;35(11):223. doi: 10.1007/s11095-018-2505-3. Pharm Res. 2018. PMID: 30280273
-
The accelerated blood clearance phenomenon of PEGylated nanoemulsion upon cross administration with nanoemulsions modified with polyglycerin.Asian J Pharm Sci. 2018 Jan;13(1):44-53. doi: 10.1016/j.ajps.2017.07.003. Epub 2017 Aug 7. Asian J Pharm Sci. 2018. PMID: 32104377 Free PMC article.
-
Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targeting.J Drug Deliv. 2013;2013:705265. doi: 10.1155/2013/705265. Epub 2013 Mar 7. J Drug Deliv. 2013. PMID: 23533772 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources